THE SYMPATHOMIMETIC EFFECTS OF 2-PYRIDINE ALDOXIME METHYLCHLORIDE (2-PAM CL).
D000818:Animals; D001285:Atropine; D001769:Blood; D001794:Blood Pressure; D002395:Catecholamines; D002415:Cats; D011756:Diphosphates; D004285:Dogs; D005724:Ganglia; D005730:Ganglionic Blockers; D006321:Heart; D006584:Hexamethonium Compounds; D008737:Methyl Chloride; D009132:Muscles; D009431:Neural Conduction; D009538:Nicotine; D009541:Nictitating Membrane; D009638:Norepinephrine; D010600:Pharmacology; D010643:Phenoxybenzamine; D011220:Pralidoxime Compounds; D012106:Research; D012110:Reserpine; D012771:Shock, Hemorrhagic; D013562:Sympathectomy; D013566:Sympathomimetics
D002395:Catecholamines; D011756:Diphosphates; D005730:Ganglionic Blockers; D006584:Hexamethonium Compounds; D011220:Pralidoxime Compounds; D013566:Sympathomimetics; D010643:Phenoxybenzamine; D009538:Nicotine; D001285:Atropine; D012110:Reserpine; D008737:Methyl Chloride; C028797:pralidoxime; D009638:Norepinephrine
ATROPINE; BLOOD; BLOOD PRESSURE; CATECHOLAMINES; CATS; DOGS; EXPERIMENTAL LAB STUDY; GANGLIA; GANGLIONIC BLOCKADERS; HEART; HEXAMETHONIUM COMPOUNDS; MUSCLES; NEURAL CONDUCTION; NICOTINE; NICTITATING MEMBRANE; NOREPINEPHRINE; PHARMACOLOGY; PHENOXYBENZAMINE; PRALIDOXIME COMPOUNDS; PYROPHOSPHATES; RESERPINE; SHOCK, HEMORRHAGIC; SYMPATHECTOMY; SYMPATHOMIMETICS